The association between ABO blood groups and TASC II classification in patients with peripheral artery disease
- 8 January 2022
- journal article
- research article
- Published by SAGE Publications in Vascular
- Vol. 31 (3) , 467-472
Abstract
Objective: The aim of this study was to investigate the association between blood groups and severity of peripheral artery disease (PAD) using TASC II classification. Methods: The patients who were diagnosed with PAD were retrospectively analyzed. The patients with 50% or more stenosis in the aorto-iliac or femoro-popliteal region detected by conventional or CT angiography were included in the study. These patients were divided into TASC II A, B, C, and D groups considering the severity of PAD. All patients’ blood groups were recorded and compared between TASC II groups. Results: While 38% of the study population was O blood group, 61% were non-O group. On the other hand, 90% of the entire study population were RH positive and 10% were RH negative. Non-O blood ratio was found to be significantly higher in patients with higher TASC II groups. (TASC IIA 51.6% vs. TASC IIB 57.9% vs. TASC IIC 61.3% vs. TASC IID 76.6%, p< .001) However, the frequencies of Rh types were similar in all groups. Multiple logistic regression analysis was applied for determining the predictors of severity and complexity of PAD (TASC II C and TASC II D lesions) Conclusions: Our study results revealed a clear association between ABO blood groups and severity of peripheral arterial disease. Non-O blood group was found to be the independent predictor of severe and complex PAD.Keywords
This publication has 26 references indexed in Scilit:
- ABO blood group alleles: A risk factor for coronary artery disease. An angiographic studyAtherosclerosis, 2010
- Poor Inter-observer Agreement on the TASC II Classification of Femoropopliteal LesionsEuropean Journal of Vascular and Endovascular Surgery, 2010
- Inflammation in AtherosclerosisJACC, 2009
- Relationship between ABO blood group and von Willebrand factor levels: from biology to clinical implicationsThrombosis Journal, 2007
- von Willebrand factor, endothelial dysfunction, and cardiovascular diseaseJournal of Thrombosis and Haemostasis, 2006
- Amount of H Antigen Expressed on Circulating von Willebrand Factor Is Modified by ABO Blood Group Genotype and Is a Major Determinant of Plasma von Willebrand Factor Antigen LevelsArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- ABO blood group and cardiovacular disease the Framingham studyAtherosclerosis, 1976
- The frequencies of ABO blood groups and of secretors of ABH group substances in peripheral arteriosclerosisAtherosclerosis, 1971
- RELATION OF ABO BLOOD-GROUPS TO ATHEROSCLEROSISThe Lancet, 1971
- The Plasma Concentration of Factor VIII in the Normal PopulationBritish Journal of Haematology, 1964